Woodline Partners LP Century Therapeutics, Inc. Transaction History

Woodline Partners LP

  • $11 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$13.93 - $23.62 $585,227 - $992,323
-42,012 Reduced 16.8%
208,082 $3.3 Million
Q3 2021

Nov 15, 2021
SELL
$20.8 - $31.93 $657,945 - $1.01 Million
-31,632 Reduced 11.23%
250,094 $6.29 Million
Q2 2021

Aug 16, 2021
BUY
$22.45 - $29.34 $6.32 Million - $8.27 Million
281,726 New
281,726 $8.27 Million

Others Institutions Holding IPSC

# of Institutions
67
Shares Held
36.9M
Call Options Held
8.7K
Put Options Held
10.2K
View Full List

About Century Therapeutics, Inc.

IPSC Quotes by TradingView
  • Ticker IPSC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,881,800
  • Market Cap $74.2M
  • Description
  • Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...
More about IPSC
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email